| 000 | 01555 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513162508.0 | ||
| 264 | 0 | _c19990216 | |
| 008 | 199902s 0 0 eng d | ||
| 022 | _a0028-3878 | ||
| 024 | 7 |
_a10.1212/wnl.52.2.351 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKastrukoff, L F | |
| 245 | 0 | 0 |
_aNatural killer cells in relapsing-remitting MS: effect of treatment with interferon beta-1B. _h[electronic resource] |
| 260 |
_bNeurology _cJan 1999 |
||
| 300 |
_a351-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon beta-1a |
| 650 | 0 | 4 | _aInterferon beta-1b |
| 650 | 0 | 4 |
_aInterferon-beta _xtherapeutic use |
| 650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aRemission Induction _xmethods |
| 700 | 1 | _aMorgan, N G | |
| 700 | 1 | _aZecchini, D | |
| 700 | 1 | _aWhite, R | |
| 700 | 1 | _aPetkau, A J | |
| 700 | 1 | _aSatoh, J | |
| 700 | 1 | _aPaty, D W | |
| 773 | 0 |
_tNeurology _gvol. 52 _gno. 2 _gp. 351-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.52.2.351 _zAvailable from publisher's website |
| 999 |
_c9894564 _d9894564 |
||